498 related articles for article (PubMed ID: 29921948)
1. Increased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma.
Xu D; Liang SQ; Yang H; Lüthi U; Riether C; Berezowska S; Marti TM; Hall SRR; Bruggmann R; Kocher GJ; Schmid RA; Peng RW
Br J Cancer; 2018 Jul; 119(1):65-75. PubMed ID: 29921948
[TBL] [Abstract][Full Text] [Related]
2. Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.
Kopecka J; Salaroglio IC; Righi L; Libener R; Orecchia S; Grosso F; Milosevic V; Ananthanarayanan P; Ricci L; Capelletto E; Pradotto M; Napoli F; Di Maio M; Novello S; Rubinstein M; Scagliotti GV; Riganti C
Lung Cancer; 2018 Jun; 120():34-45. PubMed ID: 29748013
[TBL] [Abstract][Full Text] [Related]
3. The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress.
Rozpedek W; Pytel D; Mucha B; Leszczynska H; Diehl JA; Majsterek I
Curr Mol Med; 2016; 16(6):533-44. PubMed ID: 27211800
[TBL] [Abstract][Full Text] [Related]
4. PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.
Salaroglio IC; Panada E; Moiso E; Buondonno I; Provero P; Rubinstein M; Kopecka J; Riganti C
Mol Cancer; 2017 May; 16(1):91. PubMed ID: 28499449
[TBL] [Abstract][Full Text] [Related]
5. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R
Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
[TBL] [Abstract][Full Text] [Related]
6. Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy.
Yu M; Lun J; Zhang H; Wang L; Zhang G; Zhang H; Fang J
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1417-1427. PubMed ID: 34664059
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma.
Xu D; Yang H; Yang Z; Berezowska S; Gao Y; Liang SQ; Marti TM; Hall SRR; Dorn P; Kocher GJ; Schmid RA; Peng RW
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31597321
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stress.
Feng YX; Sokol ES; Del Vecchio CA; Sanduja S; Claessen JH; Proia TA; Jin DX; Reinhardt F; Ploegh HL; Wang Q; Gupta PB
Cancer Discov; 2014 Jun; 4(6):702-15. PubMed ID: 24705811
[TBL] [Abstract][Full Text] [Related]
9. JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells.
Zanellato I; Colangelo D; Osella D
Curr Cancer Drug Targets; 2018; 18(8):816-828. PubMed ID: 28669341
[TBL] [Abstract][Full Text] [Related]
10. Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells.
Rodvold JJ; Chiu KT; Hiramatsu N; Nussbacher JK; Galimberti V; Mahadevan NR; Willert K; Lin JH; Zanetti M
Sci Signal; 2017 Jun; 10(482):. PubMed ID: 28588081
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.
Merlot AM; Shafie NH; Yu Y; Richardson V; Jansson PJ; Sahni S; Lane DJR; Kovacevic Z; Kalinowski DS; Richardson DR
Biochem Pharmacol; 2016 Jun; 109():27-47. PubMed ID: 27059255
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of eIF2α suppresses cisplatin-induced p53 activation and apoptosis by attenuating oxidative stress via ATF4-mediated HO-1 expression in human renal proximal tubular cells.
Ju SM; Jo YS; Jeon YM; Pae HO; Kang DG; Lee HS; Bae JS; Jeon BH
Int J Mol Med; 2017 Dec; 40(6):1957-1964. PubMed ID: 29039478
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma Cells.
Shukuya T; Oyanagi J; Serizawa M; Watanabe M; Yamamoto N; Koh Y
Anticancer Res; 2020 Apr; 40(4):1867-1874. PubMed ID: 32234874
[TBL] [Abstract][Full Text] [Related]
15. Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells.
Rao M; Atay SM; Shukla V; Hong Y; Upham T; Ripley RT; Hong JA; Zhang M; Reardon E; Fetsch P; Miettinen M; Li X; Peer CJ; Sissung T; Figg WD; De Rienzo A; Bueno R; Schrump DS
Clin Cancer Res; 2016 Mar; 22(5):1197-210. PubMed ID: 26459178
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study.
Cova E; Pandolfi L; Colombo M; Frangipane V; Inghilleri S; Morosini M; Mrakic-Sposta S; Moretti S; Monti M; Pignochino Y; Benvenuti S; Prosperi D; Stella G; Morbini P; Meloni F
Int J Nanomedicine; 2019; 14():773-785. PubMed ID: 30774332
[TBL] [Abstract][Full Text] [Related]
17. Co-occurring Mutations of Tumor Suppressor Genes,
Tranchant R; Quetel L; Tallet A; Meiller C; Renier A; de Koning L; de Reynies A; Le Pimpec-Barthes F; Zucman-Rossi J; Jaurand MC; Jean D
Clin Cancer Res; 2017 Jun; 23(12):3191-3202. PubMed ID: 28003305
[No Abstract] [Full Text] [Related]
18. The endoplasmic reticulum mitochondrial calcium cross talk is downregulated in malignant pleural mesothelioma cells and plays a critical role in apoptosis inhibition.
Patergnani S; Giorgi C; Maniero S; Missiroli S; Maniscalco P; Bononi I; Martini F; Cavallesco G; Tognon M; Pinton P
Oncotarget; 2015 Sep; 6(27):23427-44. PubMed ID: 26156019
[TBL] [Abstract][Full Text] [Related]
19. Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.
Li J; Li T; Li S; Xie L; Yang YL; Lin Q; Kadoch O; Li H; Hou S; Xu Z
J Investig Med; 2019 Feb; 67(2):338-345. PubMed ID: 30367010
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.
Quispel-Janssen JM; Badhai J; Schunselaar L; Price S; Brammeld J; Iorio F; Kolluri K; Garnett M; Berns A; Baas P; McDermott U; Neefjes J; Alifrangis C
Clin Cancer Res; 2018 Jan; 24(1):84-94. PubMed ID: 29061644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
